Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 6 | $40,878,105 |
| Sells | 19 | $9,209,275 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 30 Sep 2024 19:12 | VRDN | Viridian Therapeutics Inc | BEETHAM THOMAS W. | Chief Operating Officer | 27 Sep 2024 | Purchase | 5,000 | 23.41 | 117,050 | D |
| 30 Sep 2024 19:10 | VRDN | Viridian Therapeutics Inc | MAHONEY STEPHEN F. | President and CEO | 27 Sep 2024 | Purchase | 21,400 | 23.33 | 499,262 | D |
| 17 Sep 2024 21:00 | VRDN | Viridian Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director , 10% | 13 Sep 2024 | Purchase | 1,600,000 | 18.75 | 30,000,000 | I |
| 24 Jan 2024 18:44 | VRDN | Viridian Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director , 10% | 22 Jan 2024 | Purchase | 476,190 | 21 | 9,999,990 | I |
| 20 Jun 2023 17:23 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | Chief Legal Officer | 16 Jun 2023 | Sale | 27 | 28.35 | 765 | D |
| 20 Jun 2023 17:23 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | Chief Legal Officer | 15 Jun 2023 | Sale | 2,269 | 28.02 | 63,577 | D |
| 06 Jun 2023 19:41 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | Chief Legal Officer | 06 Jun 2023 | Sale | 5,126 | 25.02 | 128,253 | D |
| 06 Jun 2023 19:41 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | Chief Legal Officer | 05 Jun 2023 | Sale | 499 | 25.03 | 12,490 | D |
| 06 Jun 2023 19:41 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | Chief Legal Officer | 02 Jun 2023 | Sale | 1,875 | 24.21 | 45,394 | D |
| 12 Apr 2023 19:05 | VRDN | Viridian Therapeutics Inc | MYERS SCOTT DUNSETH | Chief Executive Officer | 12 Apr 2023 | Purchase | 4,000 | 25.3697 | 101,479 | D |
| 13 Mar 2023 16:06 | VRDN | Viridian Therapeutics Inc | MYERS SCOTT DUNSETH | Chief Executive Officer | 13 Mar 2023 | Purchase | 5,500 | 29.1499 | 160,324 | D |
| 10 Mar 2023 16:05 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | General Counsel and Secretary | 09 Mar 2023 | Sale | 29,971 | 29.07 | 871,257 | D |
| 07 Feb 2023 18:35 | VRDN | Viridian Therapeutics Inc | VIOLIN JONATHAN | Chief Executive Officer | 02 Feb 2023 | Sale A | 50,000 | 36.8 | 1,840,000 | D |
| 03 Feb 2023 18:12 | VRDN | Viridian Therapeutics Inc | VIOLIN JONATHAN | Chief Executive Officer | 02 Feb 2023 | Sale | 50,000 | 36.8 | 1,840,000 | D |
| 25 Jan 2023 18:04 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | General Counsel and Secretary | 23 Jan 2023 | Sale | 6,843 | 35.66 | 244,021 | D |
| 18 Jan 2023 17:58 | VRDN | Viridian Therapeutics Inc | KATZ BARRETT | Chief Medical Officer | 17 Jan 2023 | Sale | 24,853 | 37.21 | 924,780 | D |
| 18 Jan 2023 17:58 | VRDN | Viridian Therapeutics Inc | KATZ BARRETT | Chief Medical Officer | 13 Jan 2023 | Sale | 4,147 | 37.01 | 153,480 | D |
| 11 Jan 2023 19:09 | VRDN | Viridian Therapeutics Inc | KATZ BARRETT | Chief Medical Officer | 10 Jan 2023 | Sale | 47,377 | 35.3 | 1,672,408 | D |
| 11 Jan 2023 19:09 | VRDN | Viridian Therapeutics Inc | KATZ BARRETT | Chief Medical Officer | 09 Jan 2023 | Sale | 12,623 | 33.04 | 417,064 | D |
| 22 Dec 2022 16:42 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | General Counsel and Secretary | 21 Dec 2022 | Sale | 16,326 | 29.19 | 476,556 | D |
| 22 Dec 2022 16:42 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | General Counsel and Secretary | 20 Dec 2022 | Sale | 600 | 28.07 | 16,842 | D |
| 19 Dec 2022 19:22 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | General Counsel and Secretary | 16 Dec 2022 | Sale | 1,297 | 28.44 | 36,887 | D |
| 19 Dec 2022 19:22 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | General Counsel and Secretary | 15 Dec 2022 | Sale | 300 | 28.08 | 8,424 | D |
| 14 Dec 2022 20:56 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | General Counsel and Secretary | 14 Dec 2022 | Sale | 15,656 | 28.12 | 440,247 | D |
| 14 Dec 2022 20:56 | VRDN | Viridian Therapeutics Inc | MEISNER LARA | General Counsel and Secretary | 12 Dec 2022 | Sale | 600 | 28.05 | 16,830 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)